Amol Akhade, Senior Consultant at Fortis Hospitals Mumbai, shared a post on LinkedIn:
“Calling all oncologists treating ovarian cancer.
Your experience can help improve our understanding of how KELIM is used in routine clinical practice worldwide.
If you manage patients with ovarian cancer, please consider participating in the International KELIM Practice and Attitude Survey.
It takes only a few minutes to complete, and your contribution will help generate valuable global insights into KELIM adoption and clinical decision-making.
Please take the survey and share it with colleagues in gynecologic oncology and medical oncologist.
Survey done by Uddiptya Goswami and Kresmir Tomic from Bosnia”
Other articles featuring Amol Akhade on OncoDaily.